An abnormal mammogram often will detect a mass, a cluster of calcifications, or both; these findings are not pathognomonic and require a tissue diagnosis to confirm the presence of invasive cancer, in situ cancer, or a nonmalignant process. Although mammography is very sensitive, its abnormaliti...
Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening mammography program of British Columbia. Can J Public Health. 2000; 91 (2):113–117. [ PubMed ]Olivotto IA, Kan L, King S. Waiting for a diagnosis after an abnormal screening ...
A better diagnostic marker is in need to distinguish breast cancer from suspicious breast lesions. The abnormal glycosylation of haptoglobin has been documented to assist cancer diagnosis. This study aims to evaluate disease-specific haptoglobin (DSHp)-
Borugian MJ, Kan L, Chu CC, et al. Facilitated “fast track” referral reduces time from abnormal screening mammogram to diagnosis. Can J Public Health. 2008; 99 :252–256.Borugian MJ, Kan L, Chu CC, Ceballos K, Gelmon KA, Gordon PB, Poole B, Tyldesley S, Olivotto IA (2008) ...
Improving the time to diagnosis after an abnormal screening mammogram. Can J Public Health. 2001;92(5):366-71.Olivotto IA, Borugian MJ, Kan L, Harris SR, Rousseau EJ, Thorne SE, Vestrup JA, Wright CJ, Coldman AJ, Hislop TG: Improving the time to diagnosis after an abnormal screening...
Facilitated “fast track” referral reduces time from abnormal screening mammogram to diagnosis. Can J Public Health. 2008; 99 :252–256.Borugian MJ, Kan L, Chu CC, Ceballos K, Gelmon KA, Gordon PB, Poole B, Tyldesley S, Olivotto IA (2008) Facilitated "fast track" referral reduces ...
This procedure reduces the noises that are high or low intensity, makes all images uniform, and helps DNNs produce accurate features for normal and abnormal parts of BrC tissue. However, few studies (6 out of 80) remove various artifacts such as labels, opacity, wedges, markers, and pectoral...
Several studies have demonstrated the value of artificial intelligence (AI) applications in breast cancer diagnosis. The systematic review of AI applications in breast cancer diagnosis includes several studies that compare breast cancer diagnosis and AI.
Figure 5. Abnormal signs in LISS dataset. (ii) LIDC-IDRI Dataset The LIDC-IDRI dataset is the world’s biggest publicly available database for researchers and consists of thoracic CT images (1018 CT scan images) from 1010 patients (Figure 6). These images show the presence of lung cancers...
(C) Ultrasound showed a 3.2 cm mass (arrows) and abnormal axillary nodes (not shown). Core biopsy confirmed invasive ductal carcinoma. This is an interval cancer. Mortality reduction is significantly lower in women with dense breasts. Using data from the Nijmegen (Dutch) screening program, ...